Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs

Nat Rev Endocrinol. 2019 Dec;15(12):701-712. doi: 10.1038/s41574-019-0266-7. Epub 2019 Oct 15.


Of all the novel glucoregulatory molecules discovered in the past 20 years, bile acids (BAs) are notable for the fact that they were hiding in plain sight. BAs were well known for their requirement in dietary lipid absorption and biliary cholesterol secretion, due to their micelle-forming properties. However, it was not until 1999 that BAs were discovered to be endogenous ligands for the nuclear receptor FXR. Since that time, BAs have been shown to act through multiple receptors (PXR, VDR, TGR5 and S1PR2), as well as to have receptor-independent mechanisms (membrane dynamics, allosteric modulation of N-acyl phosphatidylethanolamine phospholipase D). We now also have an appreciation of the range of physiological, pathophysiological and therapeutic conditions in which endogenous BAs are altered, raising the possibility that BAs contribute to the effects of these conditions on glycaemia. In this Review, we highlight the mechanisms by which BAs regulate glucose homeostasis and the settings in which endogenous BAs are altered, and provide suggestions for future research.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bile Acids and Salts / metabolism*
  • Biomedical Research / trends*
  • Glucose / metabolism*
  • Glycemic Index / physiology*
  • Humans
  • Insulin / metabolism*
  • Metabolic Diseases / metabolism
  • Metabolic Diseases / therapy


  • Bile Acids and Salts
  • Insulin
  • Glucose